Webinar on Myriad and Monsanto

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Webinar on Myriad and Monsanto

Managing IP’s next webinar is on topical biotech patent developments in the United States, and takes place on Thursday June 27 at 5pm BST/noon EDT

Produced in association with LexisNexis, the webinar features Lawrence M Sung of BakerHostetler, Eric Bensen of Vandenburg & Feliu and Heather Boussios of Emergent BioSolutions.

The speakers will discuss last week’s US Supreme Court decision in the Myriad case on patentability of DNA as well as the recent decision in Monsanto regarding patent exhaustion. They will also touch on other recent and pending developments.

Participation in the webinar is free and listening live earns 1 CLE/CPD point per hour.

Pre-register for the webinar here: managingip.com/web-seminars.html

more from across site and SHARED ros bottom lb

More from across our site

News of Avanci hiring a senior vice president and the EPO teaming up with a French AI startup were also among the top talking points
Explosm, the independent Texas studio behind the hit webcomic Cyanide & Happiness, partnered with Temu’s IP protection team to combat counterfeiters infringing on its brand
The latest in a dispute over juicing machines, and a shakeup in judicial compositions were also among the top developments
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
Emma Green, partner at Bird & Bird, shares why the Iceland v Iceland dispute could prompt businesses and lawyers to think differently about brand enforcement
Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Gift this article